Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
26.09 USD | +0.93% | +4.11% | -4.36% |
Strengths
- The company's profit outlook over the next few years is a strong asset.
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last few months, analysts have been revising downwards their earnings forecast.
Ratings chart - Surperformance
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-4.36% | 1.13TCr | - | ||
+11.76% | 13TCr | A- | ||
+4.02% | 904.16Cr | C | ||
+38.12% | 555.8Cr | B+ | ||
-23.70% | 472.49Cr | C | ||
+8.55% | 345.24Cr | C- | ||
-6.44% | 286.32Cr | B- | ||
-5.85% | 207.45Cr | - | ||
-11.84% | 204.2Cr | - | - | |
-23.36% | 177.15Cr | - | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- SN. Stock
- SNN Stock
- Ratings Smith & Nephew plc